Celgem 200mg Injection
By Celgem
Rx
1 Injection in a Vial

Composition
Gemcitabine(200mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
August, 2025

liver
There is only limited information available regarding the use of Celgem 200mg Injection in patients with liver disease. It is advised to consult with your doctor for proper guidance and assessment before using this medication to ensure its safety and efficacy.

kidney
Limited information is available on using Celgem 200mg Injection in kidney disease patients. Prior consultation with your doctor is essential. Kidney function tests should be conducted before and monitoring is advised post-treatment.

alcohol
Celgem 200mg Injection may lead to increased drowsiness when consumed with alcohol. It is important to be cautious about this interaction.

driving
When using Celgem 200mg Injection, be cautious when driving as it can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Celgem 200mg Injection is not recommended during pregnancy due to potential risks to the developing baby. In life-threatening situations, the doctor may prescribe it after considering the benefits versus risks. Consult your doctor before using.

breastfeeding
Celgem 200mg Injection is not safe for use during breastfeeding as it may harm the baby. It is advised to avoid breastfeeding while using this medication.
Habit Forming | No |
Chemical Class | Cytosine Analogue |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Antimetabolites |
₹1298.32
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025